Tag: colorectal cancer patients

Filter

Thought Leadership

Product

Community

Precision Insights
Data from NantHealth’s GPS Cancer platform reveals increased opportunities for HER2 directed therapy in colorectal cancer patients
NantHealth Presented These Findings at the ASCO 2020 Gastrointestinal Cancers Symposium SAN FRANCISCO–(BUSINESS WIRE)–Jan. 25, 2020– NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based,...
Precision Insights